Supervisory Board

 

Frank Köhler – Chairman of the Supervisory Board

Frank Köhler was born in Pforzheim, Germany, in 1964. Mr. Köhler graduated from the University in Stuttgart in 1996 with a degree in technical economics (techn. Dipl.- Kfm.). After his studies, he worked in different management positions in merchandising such as Loriot Design GmbH. In 2000, he joint Aroma Company, a distributor of high-end beauty and perfume products. In 2005, he became co-owner and Director of the company, renamed Aroma Company Köhler, Frank und Weckesser, Frank GbR. Mr. Köhler expanded this business and founded Aroma Beauty and co-founded Aroma Company GmbH in the following years. Both companies are developers of perfume brands and distributors of high-end beauty and perfume products to leading perfumeries and life-style shops throughout Europe. Mr. Köhler is an expert for branding and marketing in the luxury sector. He is member of the Supervisory Board since the establishment of Shop Apotheke Europe N.V. in 2016. After the election to the Supervisory Board by the 2017 Annual General Meeting, he was appointed as Chairman of the Supervisory Board of Vita 34 AG.

Steffen Richtscheid – Deputy Chairman of the Supervisory Board

Mr. Steffen Richtscheid was born in Wolfen, Germany, in 1970. He has worked as an attorney in Leipzig since 1996 and is a partner at the Weidinger Richtscheid law office. The office specialises in the counselling and representation of companies in all areas of commercial law. Mr. Richtscheid is responsible for banking, capital markets and labour law. His clients in these fields include well-known companies. Mr. Richtscheid has been a member of the Supervisory Board of Vita 34 AG since 28/06/2017.

Dr. med. Mariola Söhngen – Member of the Supervisory Board

Dr. med. Mariola Söhngen was born in Gleiwitz, Poland, in 1961. Following her medical degree in 1987, Dr Söhngen obtained both a PhD in Medicine (1988), a Diploma in Pharmaceutical Medicine (DGPharMed, 1996) and Master of Business Communication (1999). Dr Mariola Söhngen has acquired a wealth of experience in the biotechnological and pharmaceutical industry. Since December 2019, she has been designated Co-CEO of Humanwell Pharmaceuticals B.V., the future wholly owned European subsidiary of Yichang Humanwell Pharmaceuticals Co Ltd in China. From November 2018 to December 2019, she was Managing Director of Söhngen-Consult, a consulting firm for the healthcare industry and CEO of Convert Pharmaceuticals, a drug development company focusing on oncology. Since 2016 she is member of the Supervisory Board of Vita 34 AG.

Nicolas Schobinger – Member of the Supervisory Board

Mr. Nicolas Schobinger was born 1965 in Lucerne, Switzerland. After receiving an undergraduate degree in business administration from Ludwig-Maximilian-University of Munich in 1992 he worked as Management Consultant focusing on Sales, Strategy, and Business Transformation at Gruber, Titze & Partner, Gemini Consulting and Capgemini. In 2005 Mr. Schobinger moved into an executive position at the software maker SAP, heading worldwide Strategy & Business Development for its Professional Services business and being part of the extended global leadership team. In 2017 he founded digitaliKa AG, a consulting firm specialised on Transformation and Growth for the Tech sector. In the same year he founded with partners an investment vehicle for managing investments in FinTechs thru FGI FinTech Growth Investment GmbH. He is member of the supervisory boards of the following technology companies: Member of the Supervisory Board of F24 AG/F24 Holding AG (Munich, software for alerting and crisis management). Member of the Board of Directors of FileWave AG (Switzerland, software for end device management). Member of the Board of Directors of Advanon AG (Switzerland, FinTech for financing SMEs). Furthermore he is managing partner of digitaliKa AG (Switzerland) and FGI FinTech Growth Investment GmbH (Frankfurt). Mr. Schobinger has been a member of the Supervisory Board of Vita 34 AG since 04/06/2019.

 

updated on: 20/03/2020